What is PT‑141 (Bremelanotide)?
PT‑141, also known as bremelanotide, is a synthetic peptide that acts as a melanocortin receptor agonist. Research shows it interacts with melanocortin receptors — especially MC3R and MC4R — in the brain, where it influences neural pathways involved in sexual desire and arousal. Studies also demonstrate modulation of dopaminergic and reward-related circuits in the central nervous system.
What it does / research shows
Clinical and preclinical research indicates PT‑141 modulates central nervous system signaling to increase sexual desire and arousal. It has been shown to enhance dopaminergic activity in brain regions associated with motivation and reward. It is FDA-approved under the brand name Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
Why motorcycle racers might find it interesting
The potential effects on central motivation and reward pathways may be of interest to riders seeking willpower, focus, commitment, and mental drive. Research into its neural mechanisms provides an example of how peptide signaling can influence motivation and persistence under challenging conditions.
Form & Use
Sold as a powder. To be reconstituted with bacteriostatic water before subcutaneous injection for research purposes.
Disclaimer
Sold for research purposes only. Not FDA‑approved for therapeutic use outside of labeled indications. Not intended to diagnose, treat, cure, or prevent any disease or condition. Always consult a qualified healthcare professional before use. Contact us for consultation and purchase.